News Center

Home page

Peak Report

News reports

The intelligent promotion project of pharmaceutical company was listed in the "new intelligent manufacturing" benchmark enterprise cultivation library.

Release time:

2021-12-23

"new intelligent building " enterprise cultivation library project of Jinhua economic and technological development zone, and was officially included in the benchmark enterprise cultivation library of the future factory "new intelligent building " of the development zone in 2021 . "New Wisdom Building

Project is a project carried out by Jinhua Economic and Technological Development Zone to implement the deployment requirements of digital reform in Zhejiang Province, establish and improve the promotion mechanism, accelerate the deep integration of new generation information technology and manufacturing industry, effectively stimulate the vitality of innovation and development, create a new manufacturing group led by "Future Factory " , and promote the transformation and upgrading of traditional industries. The enterprises participating in the declaration should be industrial enterprises registered and established in the development zone according to law. The application project should have the characteristics of advanced technology, great market potential, strong demonstration and driving effect, and strong industry representation. It can be recommended or declared by the township (street). The Economic Development Bureau of the Development Zone will set up and review the cultivation projects, The key cultivation projects are classified and cultivated according to the future factory, intelligent factory and digital workshop. Successful enterprises shall organize and implement pilot tasks according to the requirements, carry out the task of gathering intelligence and gathering strength to tackle key problems and create tasks. After the completion of the project implementation, they shall conduct assessment and acceptance according to the requirements of the acceptance evaluation index system. The project declared by the pharmaceutical company this time is intelligent production. The main body of the project will fully implement

DCS/SIS

system in the bulk drug workshop of Jinxi Base. Implement BMS/EMS system in clean workshop, build SCADA system and quality review and analysis system, and optimize the existing MES system, at the same time, the construction of integrated management and control platform integration to enhance the existing security and human vehicle management system. After the implementation of this project, the operation cost can be reduced. Through the implementation of automatic control, the control of reaction conditions can be more accurate, the conversion rate of materials can be improved, and the amount of waste generated can not only reduce the production cost, but also reduce the environmental protection treatment cost. The product development cycle is shortened, which is conducive to the compliance trial production of clinical samples, the high automation of chemical process and the real-time recording of parameters, and the authenticity of process data are ensured, it is conducive to the determination of various process parameters in the research and development stage and will greatly speed up the progress of product research and development. It is conducive to scientific control, scientific allocation of production factors through setting production scheduling plan, equipment management, SCADA system production whole process monitoring, etc., and comprehensively reduces the labor cost of enterprise production and management through automatic, intelligent and systematic production management. At the same time, it provides various auxiliary reports and provides data support for decision-making for management. The implementation of DCS and SIS systems can improve the degree of production automation, reduce on-site operators, meet the high-end requirements of industry safety supervision, and reduce potential production hidden dangers and various safety hidden dangers through real-time monitoring of production links, alarm of abnormal production points, and fire control of the whole plant, thus significantly improving the guarantee level of enterprise production safety. In the process of process production, the control of automatic system is fully guaranteed, which avoids the mistakes and deviations of human operation to the greatest extent. Through the monitoring and statistical analysis of production energy consumption, the energy consumption of standard products and industry energy consumption is matched, and the potential of energy saving is tapped, which is conducive to reducing the energy consumption of production, thus reducing the production cost of enterprises. It is understood that the project will be implemented on the basis of planning and detailing each module, and the installation and debugging of

DCS

, SIS , BMS and EMS systems will be completed in the later period. Other modules will be timely carried out according to the overall progress requirements, and the overall operation of SCADA system will be finally completed, project acceptance is planned for the fourth quarter of 2022 . (Yu Xun Song Shijie)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页